Provided by Tiger Trade Technology Pte. Ltd.

Avalyn Pharma

34.67
-1.2100-3.37%
Post-market: 34.670.00000.00%16:20 EDT
Volume:129.05K
Turnover:4.48M
Market Cap:1.54B
PE:-14.88
High:36.18
Open:35.26
Low:34.22
Close:35.88
52wk High:40.17
52wk Low:24.15
Shares:44.33M
Float Shares:16.67M
Volume Ratio:0.62
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3300
EPS(LYR):-87.7434
ROE:-68.34%
ROA:-41.74%
PB:3.86
PE(LYR):-0.40

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 11, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 01, 2026

Major Issues Report

Form 8-K - Current report
Jun 17, 2026

Major Issues Report

Form 8-K - Current report
Jun 03, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 03, 2026

Major Issues Report

Form 8-K - Current report
May 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 01, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 29, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 24, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 08, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933